Literature DB >> 9189266

DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis.

M Fleshner1, C R Pugh, D Tremblay, J W Rudy.   

Abstract

The authors had reported that glucocorticoids play a selective role in fear conditioning. The adrenal steroid dehydroepiandrosterone (DHEA) has been reported to act as a functional antiglucocorticoid. If DHEA has antiglucocorticoid properties, then its effects on fear conditioning might resemble those produced by adrenalectomy. The authors now report that chronic exposure to high levels of dehydroepiandrosterone sulfate (DHEA-S; converted in vivo to DHEA) produced the same pattern of results as adrenalectomy. Specifically, treatment with DHEA-S impaired contextual fear conditioning 24 hr after conditioning but not immediately after conditioning, and like adrenalectomy, DHEA-S had no effect on auditory-cue fear conditioning. Preexposure to the context before drug treatment eliminated the amnestic effects of DHEA-S, suggesting that, like adrenalectomy, DHEA-S exerted its effect by interfering with the construction of a contextual memory representation. Thus, DHEA appears to act as a functional antiglucocorticoid in the processes that mediate learning and memory.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189266     DOI: 10.1037//0735-7044.111.3.512

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  10 in total

1.  Dissociations across the dorsal-ventral axis of CA3 and CA1 for encoding and retrieval of contextual and auditory-cued fear.

Authors:  Michael R Hunsaker; Raymond P Kesner
Journal:  Neurobiol Learn Mem       Date:  2007-10-10       Impact factor: 2.877

2.  Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1.

Authors:  Ji-Liang Gao; Erich H Schneider; Eugene L Dimitrov; Forrest Haun; Therese M Pham; Abdul H Mohammed; Ted B Usdin; Philip M Murphy
Journal:  Behav Genet       Date:  2011-04-12       Impact factor: 2.805

3.  Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans.

Authors:  Christian Grillon; Daniel S Pine; Johanna M P Baas; Megan Lawley; Valerie Ellis; Dennis S Charney
Journal:  Psychopharmacology (Berl)       Date:  2005-07-29       Impact factor: 4.530

4.  Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner.

Authors:  Iulia Toth; Inga D Neumann; David A Slattery
Journal:  Psychopharmacology (Berl)       Date:  2012-04-20       Impact factor: 4.530

Review 5.  HPA Axis Interactions with Behavioral Systems.

Authors:  Amy E B Packard; Ann E Egan; Yvonne M Ulrich-Lai
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

6.  DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli.

Authors:  Rebecca K Sripada; Christine E Marx; Anthony P King; Nirmala Rajaram; Sarah N Garfinkel; James L Abelson; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2013-04-03       Impact factor: 7.853

7.  Permissive influence of stress in the expression of a U-shaped relationship between serum corticosterone levels and spatial memory errors in rats.

Authors:  Collin R Park; Adam M Campbell; James C Woodson; Taro P Smith; Monika Fleshner; David M Diamond
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

8.  Stress before puberty exerts a sex- and age-related impact on auditory and contextual fear conditioning in the rat.

Authors:  Maria Toledo-Rodriguez; Carmen Sandi
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

Review 9.  Stress and memory: behavioral effects and neurobiological mechanisms.

Authors:  Carmen Sandi; M Teresa Pinelo-Nava
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

10.  Cortisol and DHEA-S levels in pregnant women with severe anxiety.

Authors:  Philippe Leff-Gelman; Mónica Flores-Ramos; Ariela Edith Ávila Carrasco; Margarita López Martínez; María Fernanda Sarabia Takashima; Fausto Manuel Cruz Coronel; Blanca Farfán Labonne; José Antonio Zorrilla Dosal; Paola Barriguete Chávez-Peón; Saul Garza Morales; Ignacio Camacho-Arroyo
Journal:  BMC Psychiatry       Date:  2020-08-05       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.